secwatch.observer — SEC 8-K summary
======================================

Issuer:     Carisma Therapeutics Inc. (CARM)
CIK:        0001485003
Form:       8-K
Filed at:   2025-10-09T23:59:59+00:00
Accession:  0001104659-25-098404
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Carisma Therapeutics to be delisted from Nasdaq on Oct 13; expects to wind down operations
--------------------------------------------------------------------------------

- Received Nasdaq delisting letter; common stock suspended from trading effective Oct 13, 2025; no appeal planned.
- Approval received to list common stock on OTCID market tier under symbol CARM starting Oct 13, 2025.
- Company expects to pursue sale or monetization of remaining assets and orderly wind down of operations.
- Warns that it is unlikely there will be meaningful cash available for distribution to stockholders.
- May file Form 15 to suspend SEC reporting obligations after delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1485003/000110465925098404/0001104659-25-098404-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1485003/000110465925098404/tm2528458d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-098404

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer